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Abstract: Prostate cancer (PCa) is the second-leading cause of cancer-related death among men. 
microRNAs have been identified as having potential roles in tumorigenesis. An oncomir, miR-21, is 
commonly highly upregulated in many cancers, including PCa, and showed correlation with the 
Wnt-signaling axis to increase invasion. Wnt-11 is a developmentally regulated gene and has been 
found to be upregulated in PCa, but its mechanism is unknown. The present study aimed to investigate 
the roles of miR-21 and Wnt-11 in PCa in vivo and in vitro. First, different Gleason score PCa tissue 
samples were used; both miR-21 and Wnt-11 expressions correlate with high Gleason scores in PCa 
patient tissues. This data then was confirmed with formalin-fixed paraffin cell blocks using PCa cell lines 
LNCaP and PC3. Cell survival and colony formation studies proved that miR-21 involves in cells’ 
behaviors, as well as the epithelial-mesenchymal transition. Consistent with the previous data, silencing 
miR-21 led to significant inhibition of cellular invasiveness. Overall, these results suggest that miR-21 
plays a significant role related to Wnt-11 in the pathophysiology of PCa. 
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1. Introduction  
Prostate cancer (PCa) is the development of carcinoma within the prostate gland of the male 
reproductive system. It is a heterogeneous disease and may present itself as an indolent or aggressive 
form [1]. In most cases of PCa, the disease progresses at a slow rate, and symptoms often only occur 
at later stages when it is metastasized to secondary sites within the body, such as the bones, often 
leading to mortality. Overall, 10-year survival rates within patients are at an average of 84%, but this 
decreases with age (Cancer Research, UK). Currently, there is no specific form of screening for PCa, 
and health practitioners may use a combination of several tests in order to diagnose a patient. A 
grading system known as the Gleason score (GS) is in use as a guide, alongside several other factors, 
in order to determine the aggressiveness of cancer and the potential type of treatments that may be 
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required [2]. Tumors with lower GS indicate cells that are similar to normal cells and are likely to be 
less aggressive. In contrast, those assigned with higher scores are indicative of tumors with poorly 
differentiated cells, and they are more aggressive [3]. The prostate-specific antigen testing (PSA) is 
another method used in screening for PCa; however, this method has raised some controversy, as it 
has been previously associated with over-diagnosis and false-positive results in patients, because it 
is not PCa-specific. Therefore, more specific biomarkers are required for PCa diagnosis and 
prognosis.  
MicroRNAs (miRs) are highly conserved small non-coding RNAs that control gene expression 
and regulate biological processes by targeting messenger RNAs (mRNAs). miRs can inhibit or 
enhance mRNA degradation [4]. Oncogenic miRNAs promote tumor development and often lead to 
poor prognosis [5]. miR-21 is one of the oncogenic miRs located on chromosome 17q23.1 and often 
found to have an altered expression profile in many cancers, including PCa [6]. miR-21 is thought to 
play an important role in the survival of the tumor cell via metastasis and proliferation, such as 
regulating tumor-suppressor gene phosphatase tensin homolog (PTEN) in PCa [7,8]. The 
phosphatase product of PTEN acts to dephosphorylate the phosphatidylinositol 3,4,5 triphosphate 
(PIP3), which, in turn, leads to the inhibition of the PI3K/AKT signaling pathway, preventing 
uncontrolled cell proliferation [9]. Various studies have shown the transfection of miR-21 into 
metastatic PCa cell line PC3 resulted in a further increase in cell viability and proliferation, as well as 
invasion [10]. In addition to this, decreased expression of PTEN in cells transfected with miR-21 
confirms miR-21 negatively regulates PTEN. Moreover, functional studies of miR-21 revealed its 
function as an antiapoptotic factor across various cell types, whereby the expression of miR-21 was 
found to directly influence the upregulation of antiapoptotic genes such as Bcl-2 and Survivin, 
alongside pro-proliferation genes known as MMP2 and MMP9 [11]. 
Wnt-11 is a member of the Wnt signaling pathway, which is activated during embryogenesis for 
normal development, and recently, its upregulation was found in various malignancies, including 
PCa [12–14]. Wnt-11 is found to be upregulated in metastatic disease, and more importantly, it has 
been shown that it involves in TGF-β signaling pathways during the epithelial-to-mesenchymal 
transition (EMT), which is important for prostate cancer cell migration and invasion [13]. Several 
miRNAs have been reported as being associated with Wnt-signaling pathway genes [15]. A recent 
study by using meta-analysis showed that miR-21 is a good diagnostic biomarker for PCa [16]; both 
Wnt-11 and miR-21 were linked to EMT [17].  
Currently, androgen (AR) deprivation therapy remains as one of the main therapeutic 
approaches for PCa [15]. However, this method of therapy is found to have a short period of positive 
response within patients, as they eventually progress into a castration-resistant state [18]. At this 
stage, cancer becomes AR-insensitive and is no longer responsive to deprivation therapy. miR-21 has 
been found to be particularly upregulated in castration-resistant PCa [19]. Furthermore, elevated 
miR-21 in LNCaP cell lines proved to be sufficient in rescuing cells from AR-ablated growth arrest 
and instead allowed AR independent growth [20]. Moreover, miR-21′s contribution to AR receptor-
negative PCa cells showed that, by partially inhibiting the expression of miR-21, the growth of AR-
independent PC3 and DU145 cells became impaired [20]. Taken together, the results from these 
studies reaffirm the role that miR-21 may play in PCa and its potential not only as a biomarker but 
also as a therapeutic target. In this study, we aimed to elucidate if Wnt-11 and miR-21 are associated 
at the first in a clinical setting in vivo and in vitro. 
2. Materials and Methods 
2.1. Cell Culture  
PCa cell lines LNCaP and PC3 (ATCC, Manassas, VA, USA) were maintained in Roswell Park 
Memorial Institute (RPMI) 1640 (Gibco-Life Technologies, CA, USA) with 10% (v/v) heat-inactivated 
fetal bovine serum (Pan Biotech, Aiedenbach, Germany) and penicillin-streptomycin (10,000 units 
penicillin/mL and 10 mg streptomycin/mL) (Pan Biotech, Germany) at 37 ̊C in a humidified 5% CO2 
incubator (Hera Cell 150i, Thermo, USA). 
Biology 2020, 9, 52 3 of 14 
 
2.2. In Situ Hybridization, Cell Blocks, and Immunostaining 
PCa sections were purchased from UCL Biobank and provided as formalin-fixed, paraffin-
embedded, and sectioned for histological analysis. Representative hematoxylin-eosin-stained 
sections were examined to evaluate the histopathological characteristics of the lesion to be analyzed. 
All samples were independently reanalyzed for Gleason grade by a pathologist (A.K). Sections were 
deparaffinized and rehydrated using graded alcohol concentrations. Tissue permeabilization was 
performed using protease-K 2–15 μg/mL (Sigma-Aldrich, UK). Slides were washed in 
diethylpyrocarbonate (DEPC) water and incubated in prehybridization solution for 60 min at 37 °C, 
then an equal volume of miR probe (dig-labeled miR-21/scrambled—250 ng/μL), and incubated 
overnight. After washing with Tris-buffered saline (TBS), slides were then incubated with anti-
digoxigenin alkaline phosphatase antibody (1:600) (Roche, Burgess Hill, UK) for 60 min at room 
temperature. Slides were washed with TBS and then alkaline phosphatase buffer, followed by the 
addition of the NBT/BCIP substrate solution (Sigma Aldrich, Dorset, UK) with 1 μL of 1 μM 
levamisole, and slides were incubated overnight. Finally, the slides were washed in water and 
mounted with aqueous mountant. Cells harvested from PCa cell lines LNCaP and PC3 then were 
collected in phosphate-buffered saline (PBS) solution. Each specimen was centrifuged for 5 min at 
2700 g twice, and the pellet was suspended with 100 μl PBS. Gelatin solution (10%) was prepared, 
and 0.5 mL was added to the cell pellets. After hardening, each cell block was transferred into glass 
tubes containing neutral buffered formalin (NFB). Following washing, the blocks were kept in 70% 
alcohol in 4 degrees. Then, the blocks were immersed with 100% alcohol for 60 min and xylene for 45 
min twice before embedded in paraffin at 60 °C for 45 min. Finally, the cellblocks of the cell lines were 
cut at 5 μm and used in the in-situ hybridization method to detect miR-21, as described above. For 
Wnt-11-staining, antigen retrieval was performed by incubation in 10 mM sodium citrate pH 6.0 and 
heating in a microwave oven at 560W for 8 min. Endogenous peroxidase was quenched using 3% 
H2O2 for 30 min. Following blocking (30 min in PBS with 1.5% horse serum), sections were incubated 
with goat anti-Wnt-11 at 1:200 for 1 h at room temperature. Washing and antibody visualization was 
done using the Vectastain Elite ABC Standard kit according to the manufacturer’s instructions 
(Vector Labs, Southgate, UK). Tissue samples were scored by A.W. for miR-21 and Wnt-11 levels in 
PCa epithelial cells (0 = no signal, 1 = positive, and 2 = strongly positive). 
2.3. RNA Extraction and qRT-PCR  
RNA was extracted from cells using Trizol (Sigma, Haverhill, UK), and RNA concentration and 
purity were measured using the NanoDrop spectrophotometer (Thermo Fisher Scientific, Hemel 
Hempstead, UK) at 260 nm and 280 nm absorbance. RNA was reverse-transcribed to cDNA using the 
qScript microRNA cDNA Synthesis Kit (Quantabio, Lutterworth, UK) according to the 
manufacturer’s instructions. The resulting cDNA was used to assess the expression of miR-21, while 
RNU6 and hsa-let-7a-5p were used as a reference RNA for normalization of miRNA expression levels, 
as described before [21]. Each experiment was repeated six times in duplicates. The relative 
expression of miR-21 was normalized with RNU6 and let-7 expressions using the comparative cycle 
threshold method [22]. In addition, the standard deviation was calculated as well as a t-test using 
Graphpad Prism 7.00 (La Jolla, CA, USA) software. 
2.4. Assays for Colony Formation and Soft Agar Colony Formation Spheroids  
Anti-miR-21 (60 nM) transfection was performed on the LNCaP and PC3 cell lines. Briefly, anti-
miR-21 transiently transfected cells were seeded at 1x104 density in 6-well plates and incubated for 
14 days. After media was removed and cells were washed with 1x PBS solution, they were fixed with 
methanol:acetic acid (3:1) for 20 min at room temperature. Then, the removal of fixing agents: cells 
were stained with 0.5% crystal violet in methanol for 15 min and were washed by distilled water, and 
the morphological images were taken under light microscopy. For the soft agar colony formation 
assay, 0.5% agarose and 2x RPMI at a ratio of 1:1 were mixed and applied to the bottom layer of the 
6-well plates. Once the lower layer of agar had solidified, the upper layer was prepared. Then, in the 
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microfuge tube was prepared a total volume of 1 mL (0.3% agarose solution, 5 × 104 cells in 2× 
medium), and the solution was placed on the solidified agar. The plate was incubated at 37°C in an 
incubator for 21 days. Colony formation potentials were examined by light microscopy. The diameter 
of the spheroid formation was analyzed by using the Olympus Micro DP Manager Image Analysis 
program in a time-dependent manner and figured out by graphics using a 4.04 version of GraphPad 
software. 
2.5. Assays for Cell Invasion, Migration, and Apoptosis  
Cell invasion assays were performed as described before [20]. PC3 cells were transfected with 
anti-miR-21 after 48 h, and 5 × 105 transfected cells were plated on Matrigel-coated Transwell filters 
(BD Biosciences, Nottingham, UK) in growth medium containing 1% FCS. After a further 24 h, the 
number of invaded cells was determined by crystal violet assay. Wound-healing cell migration assay 
was performed briefly by seeding the cells in a monolayer, then scratched with the narrow end of a 
sterile 10 μl pipette tip. The width of the scratch was measured at different points in each well after 
initial wounding. The cells were incubated for 24 h at 37 °C in a CO2 incubator, and then the scratch 
width was measured. The relative motility and migration ability of the cells into the cell-free zone is 
expressed as the normalized percent change in the scratch width after 0, 24, and 48 h. 
2.6. Hanging Drop Assay  
PC3 cells were counted and calculated to be 25x102 each drop (for the Anti-miR-21 were used 
anti-miR-21 transfected cells). The cells were seeded in a 60-mm plate lid as 10 μl drops. Plate lid was 
gently flipped upside down and place on a plate filled with 3ml 1x PBS (to humidify the drops). The 
cells were incubated at 37°C in a CO2 incubator. Three-dimensional spheroid formations were 
examined under a light microscope for 96 h with every 24 h calculation for randomly selected at least 
10 spheroids. After 72 h, each drop was stained with DAPI and DiOC6 and examined under 
fluorescence microscopy (Olympus, Tokyo, Japan). 
2.7. Boyden Chamber Assay 
Cell migration was assayed by using modified Boyden chambers with an 8-μm pore Track-
etched polyethylene terephthalate (PET) membrane (Fisher Scientific, Loughborough, UK). 
Cells/well (25x104) were seeded after transfection protocols were proceeded in a 200-μl serum-free 
medium in the chamber. Medium (750 μl) (+serum) was added to the lower chamber. Cells were 
incubated at 37°C in CO2 for 12–24 h. Cells were fixed with 3.7% formaldehyde for 2 min at room 
temperature (RT). Formaldehyde was removed, and cells were washed with 1x PBS. Methanol (100%) 
was used for permeabilization for 20 min at RT. Cells were washed with 1x PBS twice and stained 
with crystal violet. Stained cells were visualized by light microscopy at x100 magnification. Cells 
were counted for five random fields and analyzed.  
2.8. Western Blotting 
miR-21 transfected-LNCaP and PC3 cells were scraped with 1× PBS. Then, the cells were washed 
with ice-cold 1× PBS and lysed in M-PER mammalian protein extraction reagent (Thermo Scientific, 
Waltham, MA, USA) with protease inhibitor cocktail. After lysis, cells were centrifuged for 20 min at 
16,000g at 4 °C, and total protein concentrations were determined with a Bradford protein assay (Bio-
Rad, Hercules, CA, USA). Protein isolation procedure also proceeded for DU145 and PC3 spheroids as 
3D cell cultures. Then, 30-μg of total protein was separated on 12% sodium dodecyl sulfate-
polyacrylamide gels (SDS-PAGE) and transferred difluoride (PVDF) membranes (Thermo Scientific, 
Whaltham, MA, USA). Following the washing of membranes in Tris-buffered saline with Tween-20 
(TBS-T) (10 mM Tris-HCl, pH.8.0, 0.05% Tween-20), PVDF membranes were blocked by 5% skim milk 
containing TBS-T milk 1 h at room temperature. Then, PVDF membranes were incubated in primary 
antibody buffer containing 5% (v/v) skim milk solution (E-cadherin (1:1000), β-catenin (1:1000), LRP6 
(1:1000), Wnt-11 (1:100), Dvl-2 (1:1000), Axin-1 (1:1000), and β-actin (1:1000) (Cell-Signaling Technology, 
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Danvers, MA, USA) overnight at 4 °C. Then, membranes were rinsed with TBS-T and incubated with 
horseradish peroxidase (HRP)-conjugated secondary antibodies (anti-rabbit IgG or anti-mouse IgG 
(Cell-Signaling Technology, Danvers, MA, USA) for overnight at 4 °C. Membranes were developed 
with an enhanced chemiluminescence reagent. All proteins were quantified relative to the loading 
control β-actin. 
2.9. Data Analysis 
All data were analyzed as means ± standard errors. Statistical significance was determined using 
a Student’s t-test or ANOVA with a Newman-Keuls post-hoc analysis, as appropriate. Results were 
considered significant for p < 0.05. Two-way ANOVA Bonferroni’s multiple comparisons test was 
performed using GraphPad Prism version 7.00 for Windows (GraphPad Software, La Jolla, CA, USA) 
www.graphpad.com. Western blotting results were analyzed with Image J, and obtained results were 
statistically analyzed with GraphPad Prism version 7.00 (La Jolla, CA, USA). 
3. Results 
In this study, four sets of results are presented. First, we describe the miR-21 and Wnt-11 
expression profiles of different Gleason score patient samples; we demonstrate that both miR-21 and 
Wnt-11 expressions correlate with high Gleason scores in PCa patient tissues. Second, we show that 
miR-21 affects cell survival and colony formation. Third, we demonstrate that mir-21 orchestrates the 
epithelial-mesenchymal transition. Fourth, we reveal that silencing miR-21 expression results in 
significant inhibition of cellular invasiveness. Overall, these results suggest that miR-21 plays a 
significant role in the pathophysiology of PCa. 
3.1. miR-21 and Wnt-11 Expression Profiling 
Wnt-11 protein levels are elevated in patient tumors; we used anti-Wnt-11 antibodies to localize 
Wnt-11 expression in sections taken from prostate tumor tissue samples. Twenty Gleason scores of 7 
in PCa tissue samples were used for this study, as well as ten Gleason scores higher than 7 and ten 
Gleason scores lower than 7 in tissue samples. Immunohistochemical analysis of Wnt-11 in tumor 
tissues indicated that the level of Wnt-11 was elevated in 25/36 (69.4%; Figures 1A and B). The overall 
scores were presented in Table 1. The level of Wnt-11 expression was generally higher in Gleason 
scores of 7 in PCa samples compared to lower Gleason scores in prostate samples (Figure 1A). 
Analysis in relation to conventional prognostic indices of PCa showed a negative correlation with the 
Gleason grade; Wnt-11 was more frequently found in Gleason 7 grade 4 tumors, suggesting that Wnt-
11 perhaps is an important marker during the mid-stage of cancer.  






Gleason < 7 
(n = 10) 
1/10 (10%) strong/moderate 
1/10 (10%) weak  
8/10 (80%) cases  
nonspecific 
1/9 (10%) strong/moderate  
2/10 (20%) weak  
7/10 (70%) negative/nonspecific 
Gleason 7 
(n = 20) 
8/17 (48%) strong/moderate 
7/17 (42%) weak  
2/17 (10%) nonspecific 
7/17 (42%)  
7/17 (42%) weak 
3/17 (16%) nonspecific  
Gleason > 7 
(n = 10) 
3/9 (33%) strong/moderate 
5/9 (56%) weak  
1/9 (11%) nonspecific 
4/9 (44%) strong/moderate 
4/9 (44%) weak  
1/9 (11%) nonspecific 
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Similarly, miR-21 was variably expressed in the tumor epithelial cells (Figures 1C-D and Table 
1). Nonspecific staining was observed when a scrambled probe was used in all samples. Formalin-
fixed paraffin cell blocks were prepared using LNCaP and PC3 PCa cell lines. miR-21-staining of PC3, 
a strongly metastatic PCa cell line, was intense compared with the weakly metastatic LNCaP cell line 
(n = 6; Figure 2A). The same cell lines were used to analyze miR-21 expression by qRT-PCR; 
upregulated miR-21 expression was noted in PC3 (120-fold compared to LNCaP cells; n = 6; p < 0.01) 
cells, thus correlating with ISH results (Figure 2B). Taking the data together, we conclude that further 




Figure 1. Wnt-11 protein expression in prostate cancer (PCa). A. Gleason score distribution of Wnt-11 
expression shows Wnt-11 expression significantly correlates with Gleason grade (p < 0.05 between 
three groups) B. Immunohistochemical analysis of Wnt-11: (i) low Gleason score, faint cytoplasmic 
expression (black arrow) and stromal smooth muscle (red arrow) are indicated; (ii) an example of 
Gleason grade 4 tumor; and (iii) a strongly positive Gleason 5 tumor showed upregulated cytoplasmic 
expression (scale bar 100 μm). C. miR-21 expression distribution increases with the Gleason score (p 
< 0.05 between three groups) D. In-situ hybridization of miR-21-staining in a low Gleason score: (i) 
no miR-21-staining in tumor cells (black arrow), (ii) upregulated miR-21 expression on an example of 
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a Gleason grade 4 tumor, and (iii) a strong expression of an miR-21 Gleason 5 tumor (scale bar 75 μm). 
IHC: immunohistochemistry and ISH: in-situ hybridization. 
 
Figure 2. In-situ hybridization of miR-21-staining in PCa formalin-fixed paraffin cell blocks. A. 
LNCaP (upper panel) cell blocks show less miR-21 expression and PC3 cell blocks (lower panel) 
indicate upregulated miR-21 expression correlates with metastatic behavior (n = 6). miR-21-staining 
was scored according to the staining intensity by a histopathologist (A.W.). B. qRT-PCR analysis of 
expression levels of miR-21 in LNCaP and PC3 PCa cells (n = 3; p < 0.01). Data was normalized 
according to RNU6 and hsa-let-7a-5p. 
3.2. miR-21 Involves in Cell Survival and Colony Formation 
In order to evaluate the potential role of miR-21 on cell survival and on the ability to form 
colonies, we transfected cells with anti-miR-21. The efficiency of transfection was determined by 
analyzing the intracellular level of miR-21 expression. For the normalization of miR-21 expression 
levels, RNU6 Ct values of each cell line were used as internal controls. The expression levels of miR-
21 were more significantly reduced in LNCaP cells than PC3 cells. Following, we determined colony 
formation potential within 14 days to evaluate the miR-21-related cell proliferation mechanism. The 
inhibition of miR-21 resulted with a significant decrease on colony formation potential in LNCaP cells 
when compared with PC3 cells (Figure 3B). Additionally, the effect of miR-21 on tumor growth 
potential was investigated in 3D spheroid cultures. The hanging drop assay was performed to obtain 
spheroids in LNCaP cells (Figure 3C). The images shown in Figure 3C described the spheroids that 
were observed 72 h after seeding. Viable cells were determined by fluorescence microscopy after 
staining with DiOC6. Diminished miR-21 expression resulted in a significant increase in the apoptotic 
population within the core region of the spheroids, which were observed with light microscopy 
(Figure 3C). DAPI-staining consisted with a higher number of cells with DNA damage in the core 
region. In a similar way, soft agar assay was performed to observe the effect of miR-21 inhibition on 
the 3D colony cultures in LNCaP and PC3 cells. The inhibition of miR-21 significantly prevented 
colony formation in a cytostatic manner in both LNCaP and PC3 cells within 14 days, while untreated 
cells were growing (* p = 0.0367, ** p = 0.0013, and *** p = 0.0002) (Figure 4A–B). To be able to 
understand the antiproliferative and antimigratory effects of anti-miR-21 in LNCaP and PC3 cells, 
we utilized a scratch assay to understand the proliferation capacity of cells in the wounding site 
(Figure 5A–B). While anti-miR-21 treatment in LNCaP cells was effective to reduce wound closure in 
a time-dependent manner, PC3 cells were more aggressive against anti-miR-21 treatment within 48 
h. 




Figure 3. Downregulation miR-21 increased cell death in 2D and 3D cell culture environments. A. 
Anti-miR-21 transfection reduced the expression levels of miR-21 in LNCaP and PC3 cells. Obtained 
data was normalized with RNU6 levels in each cell lines. B. The long-term effects of miR-21 inhibition 
on cell proliferation and colonization was investigated by colony formation assay in LNCaP and PC3 
cells. C. Hanging drop assay was performed in order to investigate the effects of the inhibition of miR-
21 in spheroid cultures. miR-21 downregulation increased apoptotic cell populations in 3D spheroids 
of LNCaP cells. Spheroids were stained by DiOC6 (viable cells) and DAPI (nuclei). Scale bar 100 μm. 









Biology 2020, 9, 52 9 of 14 
 
Figure 4. Long-term miR-21 downregulation decreased spheroid formation in LNCaP and PC3 PCa 
cells. A. Soft agar assay was performed to evaluate the long-term effects of anti-miR-21 on LNCaP 
and PC3 cells for 7 and 14 days. B. The reduction of colony formation size was analyzed with Tukey’s 
multiple comparison test (* p = 0.0367, ** p = 0.0013, and *** p = 0.0002). Columns represented the 
average ± std. dev. of with at least 3 separate experiments with 5 separate colonies. 
 
Figure 5. miR-21 downregulation reduced the wound-healing capacity of LNCaP cells more 
effectively than PC3 cells. A. Wound-healing assay was performed to determine the effects of anti-
miR-21 on the migration capacity of LNCaP and PC3 cells. Wound closures of cells were 
photographed and analyzed periodically for 0–48 h. Columns represented the average ± std. dev. of 
at least 3 separate experiments (LNCaP, ** p = 0.0029 and PC3, ** p = 0.0036). 
3.3. miR-21 is a Strong Regulator on EMT Pathway 
To clarify the molecular mechanism of anti-miR-21 transfection, we determined the E-cadherin 
expression profile of LNCaP and PC3 cells. E-cadherin expression levels of LNCaP were higher than 
PC3 cells, and anti-miR-21 transfection increased E-cadherin expression levels in LNCaP cells but not 
in PC3. β-catenin expression levels upregulated only in LNCaP cells; also, there was a slight increase 
in PC3 cells following anti-miR-21 transfection. Untreated PC3 cells showed higher expression 
profiles of Wnt-signaling axis-regulator protein LRP than LNCaP cells. While LRP6 was 
downregulated in anti-miR-21-transfected LNCaP cells, miR-21 inhibition upregulated LRP6 slightly 
in PC3 cells. Wnt-11 expression was lower in LNCaP than PC3 cells, since miR-21 inhibition caused 
a decrease in Wnt-11 expression. Although the downregulation of Wnt-11 was examined in miR-21-
inhibited PC3 cells, it was not significant, as in LNCaP cells. Another Wnt regulator Dvl-2 
upregulated following miR-21 inhibition in each cell line. Axin levels increased with miR-21 
inhibition in each cell line but further in LNCaP cells (Figure 6A-B). Thus, we concluded that miR-21 
expression levels are crucial in the decision of EMT in PCa prognosis. To confirm the anti-EMT effect 
of anti-miR-21 treatments, we utilized the Boyden chamber experiment, which is used for the 
invasion capacity of cells, as shown in Figure 6C. While the majority of cells were motile and alive 
according to DiOC6-staining results in PC3 control samples, anti-miR-21 transfection prevented the 
invasion of cells from micro pores on Boyden chambers. 




Figure 6. miR-21 modulated EMT and Wnt-signaling-related molecular targets in LNCaP and PC3 cells. 
A. Total protein was isolated following transfection of anti-miR-21 for 48 h in LNCaP and PC3 cells. 
Western blotting was performed in order to determine expression levels of EMT-related molecular targets 
in LNCaP and PC3 cells. B. Expression levels were analyzed by Bonferroni’s multiple comparison test; * p 
< 0.05, ** p = 0.0013, and *** p = 0.00018. β-actin was used as a loading control. C-D. Boyden chamber assay 
was performed with anti-miR-21-transfected PC3 cells. Unmigrated cells were visualized by crystal violet 
staining, and cells were counted per fields that were randomly selected at ×100 magnification. 
4. Discussion 
The main results were as follows: (1) Wnt-11 and miR-21 expression occurred commonly in PCa 
tissues, and they were significantly higher in Gleason score 7 compared with lower Gleason score tissues. 
(2) miR-21 promoted cell survival and colony formation. (3) miR-21 orchestrated EMT, as well as cellular 
invasiveness, without affecting proliferative activity. Recent studies highlighted that embryonic signals, 
which are activated during carcinogenesis, renders therapy potential and increased metastasis risk, which 
leads to increased mortality rates due to cancer progression. According to the protein atlas database, Wnt-
11 is one of the embryonic signals activated during carcinogenesis that leads to poor progression [14]. We 
have previously reported that Wnt-11 leads to neuroendocrine differentiation of different PCa cell lines. 
Moreover, Wnt-11 orchestrates a number of proteins, including PKC, JNK, NF-κB, Rho, PKA, and PI3K 
[23,24]. Next-generation sequencing data-mining results from metastatic sites of castrate-resistant PCa 
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In this study, we found that Wnt-11 and miR-21 expression correlated with Gleason grade. Many 
studies demonstrated that miRNAs regulate the Wnt signaling pathway during embryogenesis, 
osteoblast differentiation, and bone formation, as well as cardiac development [26–28]. PCa has a high 
tendency to metastasize to bone, and currently, bone metastasis remains incurable, and therapies are 
limited [29]. It has been reported that FZD8 was robustly upregulated in bone-metastatic PCa cell lines 
and tissues, and FZD8 upregulation was significantly positively associated with clinical tumor 
progression and bone metastasis. FZD8 is a major Wnt-11 receptor, and Wnt-11 involvement was 
previously reported in PCa migration and invasion. Moreover, it was demonstrated that silencing FZD8 
reduced EMT [30]. Crosstalk between TGFβ and Wnt signals has been studied extensively [31]. 
Furthermore, TGFβ expression is often increased in cancer cells, where it promotes EMT, metastasis, and 
chemoresistance. Similarly, miR-21 has been found to be upregulated in many carcinomas, including PCa 
and TGFβ/BMP4-induced pri-miR-21-processing, and upregulation of the mature miR-21 was also 
observed in MDA-MB-468 breast carcinoma cells [32]. Another study demonstrated that overexpressing 
FZD8 promotes, whereas silencing FZD8 suppresses, PCa cell migration, invasion, and stem cell-like 
phenotypes in vitro through an association of FZD8 and the TGFβ receptor complex [29]. Our results are 
in line with the findings that miR-21 may regulate Wnt-11 expression, perhaps via the FZD8-TGFβ 
complex. Previous studies also demonstrated that PTEN is one of the major gene targets of miR-21. PC3 
cells do not express PTEN; however, LNCaP do. PTEN plays a significant role during cell survival and 
migration signaling and inhibits PI3K/AKT, as well as the focal adhesion-related signaling axis [33–35]. 
We have found that, after miR-21 was inhibited, the colony formation of LNCaP cells were decreased, but 
there was no clear effect on PC3 cell colony formation. Surprisingly, miR-21 inhibition alone did not affect 
cell proliferation of PCa cells. This is in line with other published studies that the downregulation of miR-
21 had no additive effect on the inhibition of cell proliferation of doxorubicin-treated A549 and OVCAR3 
cells, whereas there was an increase in sensitivity in SNB19 glioma cells [36]. In another study, 
overexpression of miR-21 caused resistance to gemcitabine of SUIT-2 and Panc-1 pancreatic cancer cells 
due to increased activity of PI3K/AKT/mTOR signaling as a consequence of the high suppression of PTEN 
by miR-21 [35]. Therefore, the inhibitive effect of anti-miR-21 on cell survival might be cell type-
dependent. In our study, we have found that the inhibition of miR-21 more efficiently suppressed the 
invasion potential of LNCaP cells compared to PC3 cells. It is known that LNCaP cells are derived from 
lymph node metastasis, and PC3 cells are derived from androgen-independent bone metastasis. 
Additionally, PC3 cells have a higher metastatic potential than LNCaP cells [37]. Jin et al. suggested that 
bone morphogenetic protein receptor II (BMPRII) is one of the targets of miR-21 and also showed that the 
protein expression level of BMPRII conversely regulated with the level of miR-21 in LNCaP and PC3 cells. 
BMPRII played an important role during stem cell differentiation and cell proliferation. Therefore, miR-
21 has potential in the regulation of the metastatic and malignancy abilities of PCa cells by BMPRII [38]. 
We have observed a remarkable effect of miR-21 inhibition on the anchorage-independent colony growth 
in LNCaP cells, which is consistent with previous results. Although hanging drops did not affect miR-21 
inhibition, colony diameters were significantly reduced in PC3 cells. The inhibiting colony formation in 
each cell line suggested that miR-21 maintained the stem cell function and migration capacity of PCa cells. 
In non-small cell lung cancer, (NSCLC)-derived cells showed elevated levels of miR-21 in anchorage-
independent growth conditions [39]. Therefore, miR-21 upregulation might explain one of the triggering 
mechanisms in malignant tumors. Our wound-healing results were also consistent with previous findings 
in LNCaP and PC3 cells, which were accompanied by the upregulation of epithelial marker E-cadherin 
expression levels in miR-21-inhibited LNCaP and PC3 cells [35]. However, β-catenin levels did not affect 
the inhibition of miR-21 in LNCaP cells, but a marked decrease in β-catenin levels was observed in PC3 
cells. Moreover, increased expression levels of miR-21 further induced the migration of glioma cells, which 
are associated with the upregulation of Sox-2 and β-catenin protein [40]. Therefore, that might be the 
reason for the resumption of migration in LNCaP cells. While LRP levels were diminished by the 
inhibition of miR-21 in LNCaP cells, there was the opposite effect in PC3 cells. The downregulation of LRP 
was important during the prevention of migration, because LRP played an important role with CD44 in 
adhesion mechanisms in tumor progression [41]. Previous studies determined that the c-Jun transcription 
factor was associated with pre-miR-21 promoter regions [42]. Prevention of the activity of JNK-1 as a main 
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activator of p-Jun decreased miR-21 expression and increased the other important target gene, PDCD4 
(tumor-suppressor gene programmed cell death 4). In ovarian cancer cells, targeting the miR-21 resulted 
in the downregulation of cell proliferation through the diminishing of the JNK-1 pathway. In addition, 
blocking miR-21 overwhelmed the cisplatin resistance in ovarian cancer cells [43]. 
We have utilized the TCGA dataset (PRAD), which includes 568 PCa patients. Following the 
selection of the prostate cancer dataset from TCGA, we ran UCSC Xena to evaluate the relationship 
between Wnt11 and the Gleason score. Wnt11 was critical in the disease progression. Kaplan Meier 
datasets showed that an increase in the copy number of Wnt11 caused a lesser progression-free survival 
and decreased the overall survival rate. In addition, we have found that higher Gleason score patients 
have the highest expression levels of Wnt11 (prostate cancer Gleason Wnt-11 file). We confirmed these 
findings by a MEXPRESS view of the TCGA dataset, which indicates that Wnt11 is a critical target in 
prostate cancer disease progression (supplementary file from TCGA). 
5. Conclusions 
Taken together, in this study, we showed that miR-21 plays an important role during cell migration 
and invasion. The EMT pathway was downregulated by the inhibition of miR-21, which demonstrated 
that miR-21 was a probable target to inhibit cell invasion but in a cell type-dependent manner. So, an 
efficient modulation of the downstream targets in the therapeutic scenario of miR-21 might depend on 
distinct regulators such as PTEN, β-catenin, or other cell migration-associated genes. Overall, these 
findings indicated that Wnt-11 and EMT pathways are maintained by miR-21. Further studies are needed 
to identify related signaling axes; however, our data and others indicate that miR-21 could be a useful 
target for PCa. 
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